|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 33/24 | |
| A61P 19/10 |
| (11) | Patento numeris | 1294384 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01940848.3 |
| Europos patento paraiškos padavimo data | 2001-06-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2009-03-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2001/002836 |
| Data | 2001-06-26 |
| (87) | Numeris | WO 2002/000227 |
| Data | 2002-01-03 |
| (30) | Numeris | Data | Šalis |
| 0015745 | 2000-06-27 | GB |
| (72) |
ATHERTON, Nigel Derek Shire Pharmac. Group PLC, GB
TOTTEN, Joseph W, Shire Pharmaceuticals Group PLC, GB
GAITONDE, Michael, David, CH
|
| (73) |
Shire Holdings AG,
Bundersstrasse 5, 6300 Zug,
CH
|
| (54) | USE OF LANTHANUM COMPOUNDS FOR THE TREATMENT OF BONE DISEASES |
| USE OF LANTHANUM COMPOUNDS FOR THE TREATMENT OF BONE DISEASES |